Based on this, we induced PD-L1 expression on the exosomes of two poorly immunogenic tumor models, B16F10 melanoma and CT26 colorectal cancer, the ICB therapeutic responses are typically poor and are correlated with tumor PD-L1 expression levels. This evidence concerns the gene CD274 and melanoma.